Ally Bridge Group (Ny) LLC Portfolio Holdings

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Ally Bridge Group (Ny) LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $141 Million distributed in 29 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $11M, Tarsus Pharmaceuticals, Inc. with a value of $10.6M, Merus N.V. with a value of $10.4M, Blueprint Medicines Corp with a value of $9.81M, and Sarepta Therapeutics, Inc. with a value of $8.99M.

Examining the 13F form we can see an increase of $34M in the current position value, from $107M to 141M.

Ally Bridge Group (Ny) LLC is based out at New York, NY

Below you can find more details about Ally Bridge Group (Ny) LLC portfolio as well as his latest detailed transactions.

Portfolio value $141 Million
Healthcare: $139 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$9.81B
$11 Million 7.83% of portfolio
150,833
Q3 2024 Added 16.92%
$1.34B
$10.6 Million 7.52% of portfolio
321,898
Q3 2024 New
$2.23B
$10.4 Million 7.39% of portfolio
208,244
Q3 2024 Added 19.1%
$5.83B
$9.81 Million 6.97% of portfolio
106,080
Q3 2024 Added 40.25%
$11.2B
$8.99 Million 6.39% of portfolio
72,000
Q3 2024 Reduced 2.04%
$2.62B
$8.33 Million 5.92% of portfolio
211,791
Q3 2024 Added 25.05%
$815M
$8.03 Million 5.71% of portfolio
240,892
Q3 2024 Added 10.01%
$4.54B
$7.41 Million 5.27% of portfolio
163,500
Q3 2024 New
$2.61B
$7.3 Million 5.18% of portfolio
227,700
Q3 2024 New
$666M
$6.35 Million 4.51% of portfolio
270,075
Q3 2024 Added 2.05%
$109M
$6.26 Million 4.45% of portfolio
1,229,292
Q3 2024 Added 145.86%
$1.53B
$6.04 Million 4.29% of portfolio
1,331,053
Q3 2024 Reduced 51.36%
$749M
$5.75 Million 4.08% of portfolio
294,081
Q3 2024 Reduced 4.13%
$81.6M
$5.26 Million 3.73% of portfolio
618,332
Q3 2024 New
$1.99B
$5.01 Million 3.56% of portfolio
187,695
Q3 2024 New
$1.6B
$4.95 Million 3.52% of portfolio
309,614
Q3 2024 New
$561M
$4.43 Million 3.15% of portfolio
626,058
Q3 2024 New
$166M
$4.42 Million 3.14% of portfolio
1,322,800
Q3 2024 Reduced 10.31%
$24.1M
$3.44 Million 2.45% of portfolio
1,757,524
Q3 2024 Reduced 6.82%
$0
$1.99 Million 1.41% of portfolio
1,592,605
Q3 2024 Added 50.31%
Alumis Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 32.38%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 52.28%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 13.75%
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 18.33%
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 50.54%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 82.73%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 39.94%

Summary

  • Portfolio
  • No. of Stocks 29
  • Current Value $141 Million
  • Prior Value $107 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email